Oncology

New York City-based Mount Sinai has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with KRAS gene mutations.  

Mayo Clinic Jacksonville (Fla.) began site work on its $233 million integrated oncology building, The Jacksonville Daily Record reported Aug. 8. 

Morganstown, W. Va-based WVU Cancer Institute became the first facility in the state to administer Pluvicto, a radiation pharmaceutical administered through injection or infusion, for a type of metastatic prostate cancer, local news website My Buckhannon reported Aug. 7.

Here are four cancer research donations and grants over $5 million that Becker's has covered since June 15: 

The FDA approved Enhertu Aug. 6, the first targeted therapy for HER2-low breast cancer.

The University of Virginia Cancer Center received gifts totaling $5.75 million from anonymous donors to speed the development of new treatments for rare blood cancers, according to an Aug. 4 press release from the university.

Researchers at Seattle-based Fred Hutchinson Cancer Center have received a four-year, $25 million federal grant to learn how to destroy metastatic cancer cells before they can spread.

Ten oncologists joined new practices or received new appointments in the last few weeks.

Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine received a $9.5 million grant Aug. 1 to investigate the most common form of esophageal cancer in the U.S.

Atlanta-based Northside Hospital Cancer Institute joined the Caris Life Sciences Precision Oncology Alliance last week.